Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 2, 2015, Pages 201-207

  Klaassen, Ester M M ^a   Van De Kant, Kim D G ^a   Jöbsis, Quirijn ^a   Van Schayck, Onno C P ^b   Smolinska, Agnieszka ^c,d   Dallinga, Jan W ^c   Van Schooten, Frederik J ^c   Den Hartog, Gertjan J M ^c   De Jongste, Johan C ^e   Rijkers, Ger T ^f,g   Dompeling, Edward ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ST ANTONIUS HOSPITAL   (Netherlands)

^g Roosevelt Academy   (Netherlands)

Author keywords

Children; Exhaled breath condensate; Gene expression; Volatile organic compounds; Wheeze

Indexed keywords

BIOLOGICAL MARKER; BRONCHODILATING AGENT; CATALASE; EXHALED BREATH CONDENSATE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

AIRWAY RESISTANCE; AREA UNDER THE CURVE; ARTICLE; ASTHMA; ASTHMA PREDICTIVE INDEX; CHILD; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SYMPTOM; WHEEZING; BLOOD; BREATH ANALYSIS; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION PROFILING; GENETICS; INFLAMMATION; METABOLISM; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; RESPIRATORY SOUNDS; STATISTICAL MODEL;

AIRWAY RESISTANCE; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CATALASE; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; LOGISTIC MODELS; MALE; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RESPIRATORY SOUNDS; ROC CURVE; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; VOLATILE ORGANIC COMPOUNDS;

EID: 84921341702     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201408-1537OC     Document Type: Article

References (47)

1. Savenije OE, Granell R, Caudri D, Koppelman GH, Smit HA, Wijga A, de Jongste JC, Brunekreef B, Sterne JA, Postma DS, et al. Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA. J Allergy Clin Immunol 2011;127:1505-1512.e14.
2. Pedersen SE, Hurd SS, Lemanske RF Jr, Becker A, Zar HJ, Sly PD, Soto-Quiroz M, Wong G, Bateman ED; Global Initiative for Asthma. Global strategy for the diagnosis and management of asthma in children 5 years and younger. Pediatr Pulmonol 2011;46:1-17.
3. Caudri D, Wijga AH, Smit HA, Koppelman GH, Kerkhof M, Hoekstra MO, Brunekreef B, de Jongste JC. Asthma symptoms and medication in the piama birth cohort: evidence for under and overtreatment. Pediatr Allergy Immunol 2011;22:652-659.
4. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 2000;162:1403-1406.
5. Kurukulaaratchy RJ, Matthews S, Holgate ST, Arshad SH. Predicting persistent disease among children who wheeze during early life. Eur Respir J 2003;22:767-771.
6. Caudri D, Wijga A, Schipper C, Hoekstra M, Postma DS, Koppelman GH, Brunekreef B, Smit HA, de Jongste JC. Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. J Allergy Clin Immunol 2009;124:903-910.e1-e7.
7. Castro-Rodriguez JA. The asthma predictive index: A very useful tool for predicting asthma in young children. J Allergy Clin Immunol 2010;126: 212-216.
8. Global Initiative for Asthma. Global strategy for the diagnosis and management of asthma in children 5 years and younger. 2009 [accessed 2013 Dec; updated 2014 Oct]. Available from: http://www.ginasthma.org
9. Expert panel, National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma 2007. 2007 [updated 2008 Aug; accessed 2013 Dec]. Available from: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm
10. Savenije OE, Kerkhof M, Koppelman GH, Postma DS. Predicting who will have asthma at school age among preschool children. J Allergy Clin Immunol 2012;130:325-331.
11. Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010;138:682-692.
12. Rosias PP, Robroeks CM, van de Kant KD, Rijkers GT, Zimmermann LJ, van Schayck CP, Heynens JW, Jöbsis Q, Dompeling E. Feasibility of a new method to collect exhaled breath condensate in pre-school children. Pediatr Allergy Immunol 2010;21:e235-e244.
13. Robroeks CM, Rijkers GT, Jöbsis Q, Hendriks HJ, Damoiseaux JG, Zimmermann LJ, van Schayck OP, Dompeling E. Increased cytokines, chemokines and soluble adhesion molecules in exhaled breath condensate of asthmatic children. Clin Exp Allergy 2010;40:77-84.
14. Kazani S, Israel E. Exhaled breath condensates in asthma: diagnostic and therapeutic implications. J Breath Res 2010;4:047001.
15. van de Kant KD, van der Sande LJ, Jobsis Q, van Schayck OC, Dompeling E. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review. Respir Res 2012;13:117.
16. Boots AW, van Berkel JJ, Dallinga JW, Smolinska A, Wouters EF, van Schooten FJ. The versatile use of exhaled volatile organic compounds in human health and disease. J Breath Res 2012;6:027108.
17. Merkus PJ, Arets HG, Joosten T, Siero A, Brouha M, Mijnsbergen JY, de Jongste JC, van der Ent CK. Measurements of interrupter resistance: reference values for children 3-13 yrs of age. Eur Respir J 2002;20:907-911.
18. Brussee JE, Smit HA, Koopman LP, Wijga AH, Kerkhof M, Corver K, Vos AP, Gerritsen J, Grobbee DE, Brunekreef B, et al. Interrupter resistance and wheezing phenotypes at 4 years of age. Am J Respir Crit Care Med 2004;169:209-213.
19. Kooi EM, Schokker S, van der Molen T, Duiverman EJ. Airway resistance measurements in pre-school children with asthmatic symptoms: the interrupter technique. Respir Med 2006;100:955-964.
20. van de Kant KD, van Berkel JJ, Jöbsis Q, Lima Passos V, Klaassen EM, van der Sande L, van Schayck OC, de Jongste JC, van Schooten FJ, Derks E, et al. Exhaled breath profiling in diagnosing wheezy preschool children. Eur Respir J 2013;41:183-188.
21. van de Kant KD, Klaassen EM, Jöbsis Q, Koers K, Rijkers GT, van der Grinten CP, van Schayck OC, Passos VL, Dompeling E. Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate. J Allergy Clin Immunol 2010;126:669-671.
22. Dallinga JW, Robroeks CM, van Berkel JJ, Moonen EJ, Godschalk RW, Jobsis Q, Dompeling E, Wouters EF, van Schooten FJ. Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Clin Exp Allergy 2010;40:68-76.
23. Cai X, Yang YC, Wang JF, Wang Q, Gao J, Fu WL, Zhu ZY, Wang YY, Zou MJ, Wang JX, et al. Transient receptor potential vanilloid 2 (trpv2), a potential novel biomarker in childhood asthma. J Asthma 2013;50:209-214.
24. Jin R, Xu HG, Yuan WX, Zhuang LL, Liu LF, Jiang L, Zhu LH, Liu JY, Zhou GP. Mechanisms elevating ORMDL3 expression in recurrent wheeze patients: role of Ets-1, p300 and CREB. Int J Biochem Cell Biol 2012;44:1174-1183.
25. Smolinska A, Klaassen EM, Dallinga JW, van de Kant KD, Jobsis Q, Moonen EJ, van Schayck OC, Dompeling E, van Schooten FJ. Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children. PLoS ONE 2014;9:e95668.
26. Klaassen EMM, van de Kant KDG, van Eys G, den Hartog GJ, van Schayck CP, Jöbsis Q, Dompeling E. The incremental diagnostic value of exhaled inflammatory markers, gene expression, and airway reversibility to the asthma predictive index in diagnosing asthma at preschool age [abstract]. Am J Respir Crit Care Med 2013;187:A3526.
27. van de Kant KD, Klaassen EM, Jöbsis Q, Nijhuis AJ, van Schayck OC, Dompeling E. Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study. BMC Public Health 2009;9:210.
28. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-1232.
29. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-338.
30. Klaassen EM, van de Kant KD, Jöbsis Q, Høvig ST, van Schayck CP, Rijkers GT, Dompeling E. Symptoms, but not a biomarker response to inhaled corticosteroids, predict asthma in preschool children with recurrent wheeze. Mediators Inflamm 2012;2012:162571.
31. Powell CV, McNamara P, Solis A, Shaw NJ. A parent completed questionnaire to describe the patterns of wheezing and other respiratory symptoms in infants and preschool children. Arch Dis Child 2002;87:376-379.
32. Just J, Nicoloyanis N, Chauvin M, Pribil C, Grimfeld A, Duru G. Lack of eosinophilia can predict remission in wheezy infants? Clin Exp Allergy 2008;38:767-773.
33. Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart 2012;98:683-690.
34. van de Kant KD, Koers K, Rijkers GT, Lima Passos V, Klaassen EM, Mommers M, Dagnelie PC, van Schayck CP, Dompeling E, Jöbsis Q. Can exhaled inflammatory markers predict a steroid response in wheezing preschool children? Clin Exp Allergy 2011;41:1076-1083.
35. Van Berkel JJ, Dallinga JW, Moller GM, Godschalk RW, Moonen E, Wouters EF, Van Schooten FJ. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. J Chromatogr B Analyt Technol Biomed Life Sci 2008;861:101-107.
36. Snee RD. Validation of regression models: methods and examples. Technometrics 1977;19:415-428.
37. Miekisch W, Schubert JK, Noeldge-Schomburg GF. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin Chim Acta 2004;347:25-39.
38. Caldeira M, Barros AS, Bilelo MJ, Parada A, Camara JS, Rocha SM. Profiling allergic asthma volatile metabolic patterns using a headspace-solid phase microextraction/gas chromatography based methodology. J Chromatogr A 2011;1218:3771-3780.
39. Caldeira M, Perestrelo R, Barros AS, Bilelo MJ, Morete A, Camara JS, Rocha SM. Allergic asthma exhaled breath metabolome: a challenge for comprehensive two-dimensional gas chromatography. J Chromatogr A 2012;1254:87-97.
40. Kovacic MB, Myers JM, Wang N, Martin LJ, Lindsey M, Ericksen MB, He H, Patterson TL, Baye TM, Torgerson D, et al. Identification of KIF3A as a novel candidate gene for childhood asthma using RNA expression and population allelic frequencies differences. PLoS ONE 2011;6:e23714.
41. van de Kant KD, Jansen MA, Klaassen EM, van der Grinten CP, Rijkers GT, Muris JW, van Schayck OC, Jobsis Q, Dompeling E. Elevated inflammatory markers at preschool age precede persistent wheezing at school age. Pediatr Allergy Immunol 2012;23:259-264.
42. Brunetti L, Francavilla R, Tesse R, Fiermonte P, Fiore FP, Lore M, Margiotta M, Armenio L. Exhaled breath condensate cytokines and pH in pediatric asthma and atopic dermatitis. Allergy Asthma Proc 2008;29:461-467.
43. Carraro S, Rezzi S, Reniero F, Heberger K, Giordano G, Zanconato S, Guillou C, Baraldi E. Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007;175:986-990.
44. Bloemen K, Van Den Heuvel R, Govarts E, Hooyberghs J, Nelen V, Witters E, Desager K, Schoeters G. A new approach to study exhaled proteins as potential biomarkers for asthma. Clin Exp Allergy 2011; 41:346-356.
45. von Jagwitz M, Pessler F, Akmatov M, Li J, Range U, Vogelberg C. Reduced breath condensate pH in asymptomatic children with prior wheezing as a risk factor for asthma. J Allergy Clin Immunol 2011;128:50-55.
46. Caudri D, Wijga AH, Hoekstra MO, Kerkhof M, Koppelman GH, Brunekreef B, Smit HA, de Jongste JC. Prediction of asthma in symptomatic preschool children using exhaled nitric oxide, Rint and specific IgE. Thorax 2010;65:801-807.
47. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-548.